FRIDAY, Oct. 5, 2018 — For patients with type 2 diabetes and acute coronary syndrome, lixisenatide can slow or prevent
Continue reading »
Home ยป
NIRS-IVUS detects patients and plaques vulnerable to subsequent adverse coronary events
Results from the Lipid-Rich Plaque (LRP) study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected
Continue reading »
Study suggests siblings of people with RA are at increased risk of acute coronary syndrome
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate an increased risk
Continue reading »
Acute coronary syndrome patients with short sleep have double odds of hospital readmission
Pilot data from a recent study suggest that patients with short sleep have over two times the odds of readmission
Continue reading »
SCAI updates consensus on length of stay for percutaneous coronary intervention
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary intervention (PCI) will allow for flexibility
Continue reading »
Are antidepressants safe in patients with coronary heart disease?
An investigation published in the current issue of Psychotherapy and Psychosomatics explores the cardiac events that may occur with the
Continue reading »